Low Dose Versus High Dose Methylene Blue in Septic Patients
Key facts
- Who runs it
- National Cancer Institute, Egypt
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2/3
- People taking part
- 90 people enrolled
- Started
- 1 Aug 2023
- Ended
- 15 May 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Normal saline
- Methylene Blue low dose
- Methylene Blue high dose
- Record updated
- 5 July 2024
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients aged ≥ 18 years and ≤ 65 with septic shock as defined by Sepsis-3 criteria (confirmed infection, requiring vasopressor to maintain a mean arterial blood pressure (MAP) ≥ 65 mmHg, and serum lactate > 2 mmol/L after adequate fluid resuscitation), and requiring mechanical ventilation
Who cannot take part
- recent intake (4-weeks) of selective serotonin re-uptake inhibitors or MAOi
- myocardial infarction or cerebrovascular accident within the last 3 months
- known allergy to MB or food dyes and the use of nitrates within the last 3 days
- severe lung , liver or kidney disease (creatinine >3.5 mg/dL)
- glucose 6-phosphate-dehydrogenase deficiency
- pregnancy
- more than 24 hrs since initiation of norepinephrine
- other causes of shock than sepsis
- refusal of the patient guardian to participate
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main aim of this study is to examine the various effects of continuous methylene blue infusion in septic cancer patients and to compare it with the traditional infusion of noradrenaline in such patients .
The 3 groups in the trial
- Normal salineExisting treatment, for comparison
30 patients will receive placebo of 100ml 0.9% Nacl over 20 minutes followed by continuous infusion of Nacl for 72 hours.
Treatment: Methylene Blue low dose and Methylene Blue high dose
- methylene blue low doseExisting treatment, for comparison
30 patients will receive a bolus of MB 1mg/kg in 100ml 0.9% Nacl over 20 minutes followed by continuous infusion of 0.25mg/kg/hour for 72 hours.
Treatment: Normal saline and Methylene Blue high dose
- methylene blue high doseExisting treatment, for comparison
30 patients will receive a bolus of MB 4mg/kg in 100ml 0.9% Nacl over 20 minutes followed by continuous infusion of 0.25mg/kg/hour for 72 hours.
Treatment: Normal saline and Methylene Blue low dose
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Study Between High and Low Dose Methylene Blue Infusion in Septic Cancer Patients. A Randomized Blinded Controlled Study
- Publications
- Record updated
- 5 July 2024